COVID-19: Expert committee approves Covaxin for children aged 2-18 years
No data on clinical trials of Bharat Biotech vaccine on children available publicly yet
Indian rotavirus vaccine found effective during clinical trial
Rotovac costs fifty times less than brands sold by global pharma companies
COVID-19: Zydus Cadila seeks emergency approval of its needleless vaccine
This needleless vaccine, in case it gets approval, will be the world’s first plasmid deoxyribonucleic acid vaccine against COVID-19 …
COVID-19: Why ICMR okayed hydroxychloroquine as preventive med
Hydroxychloroquine has been found to be effective against SARS-CoV-2 in laboratory studies
Drug pricing body puts cap on trade margin for 42 anti-cancer drugs
Experts say move will not benefit patients as drug prices are already too high and the cap only negligible
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Parliament committee indicts drugs regulatory authority
Drugs which are banned in developed countries are approved in India without clinical trials
COVID-19: Centre doesn’t clarify basis for CDSCO authorising remdesivir
Government also does not provide clarity about whether remdesivir should be given to only severe patients
Substantiate allegations against Ranbaxy, says Supreme Court
Experts say allegations against the generic pharma company motivated by vested interests
Health ministry forms committee to investigate charges by parliamentary standing committee
It will also suggest ways to improve grant of statutory approvals for drugs and functioning of the CDSCO